Pancreatic cancer vaccine trial results revealed
The vaccine successfully stimulated an immune response in half of the treated patients, resulting in no cancer relapse after 18 months.
The vaccine successfully stimulated an immune response in half of the treated patients, resulting in no cancer relapse after 18 months.